Ontology highlight
ABSTRACT: Background/objectives
Bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) is an antagonist of transforming growth factor (TGF)-β type 1 signaling. BAMBI functions as an anti-fibrotic protein and exerts pro- as well as anti-cancerogenic activities. Our study aimed to correlate hepatocyte BAMBI protein levels in hepatocellular carcinoma (HCC) with T stage, lymph node invasion, vessel invasion, grading, tumor size and Union for International Cancer Control (UICC) stage, as well as with liver inflammation and fibrosis stages.Methods
Hepatocyte BAMBI protein expression was assessed by immunohistochemistry in HCC tissues of 320 patients and non-tumor tissues of 51 patients.Results
In the HCC tissues of the whole cohort and sex-specific analysis, BAMBI
SUBMITTER: Weber F
PROVIDER: S-EPMC11504530 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature